RNAC icon

Cartesian Therapeutics
RNAC

Overview Fund Trends Analyst Outlook Journalist POV

61 hedge funds and large institutions have $85.6M invested in Cartesian Therapeutics in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

26% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 27

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$114K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.01M
2
+$6.99M
3
+$6.55M
4
BlackRock
BlackRock
New York
+$4.48M
5
LGM
Logos Global Management
California
+$2.43M

Top Sellers

1
-$23M
2
-$647K
3
-$199K
4
Invesco
Invesco
Georgia
-$159K
5
Jane Street
Jane Street
New York
-$124K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$1.05K
52
$970
53
$669
54
$436
55
$378
56
$325
57
$81
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4